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Miami, Florida 33136 Heat shock proteins are potent activators of the cellu-
lar immune response (Palliser, 2001; Singh-Jasuja et al.,
2001; Srivastava and Amato, 2001). Heat shock proteins
Summary including gp96 are released by cell death caused by
trauma, infection, or necrosis (Basu et al., 2000; Berwin
Tumor-secreted gp96-Ig is highly immunogenic and et al., 2001). Gp96-peptide complexes bind to CD91 and
triggers CD8 T cell-mediated tumor rejection. In vivo other receptors on dendritic cells (Basu et al., 2001;
secreted gp96-Ig and gp96-myc cause NK activation Berwin et al., 2002; Binder et al., 2000), mediate endocy-
and clonal expansion of specific CD8 CTL in wild- tosis and dendritic cell maturation (Singh-Jasuja et al.,
type and in Fas-ligand-deficient (gld) mice but not in 2000), and chaperone peptides into class I MHC of den-
perforin- (PKO) or IFN--deficient (GKO) mice. Trans- dritic cells and macrophages (Arnold et al., 1995; Udono
fer of perforin-competent NK cells restores the ability and Srivastava, 1993). It has been postulated that activa-
of PKO mice to clonally expand CD8 CTL in response tion of APC by gp96 is responsible for the subsequent
to gp96-Ig. The data demonstrate an essential role for CTL response in vivo.
perforin-mediated functions in the activation of innate In previous studies we generated a secreted form of
and adaptive immunity by heat shock protein gp96- gp96, gp96-Ig, by deletion of the endoplasmic reticulum
peptide complexes. Crosspresentation of antigens by retention signal and replacement with the Fc portion of
heat shock proteins seems to require a perforin- murine IgG1. When transfected into tumor cells and used
dependent positive feedback loop between NK and for immunization of mice, secreted gp96-Ig generated
DC for both sustained NK activation and clonal CTL a protective and specific immune response against sub-
expansion. The studies also explain how depressed sequent challenge with the same tumor (Yamazaki et
NK activity in patients with tumors or after viral infec- al., 1999). Immune rejection was dependent on CD8 cells
tions could diminish CTL responses. and did not require CD4 help, supporting the concept that
heat shock proteins could activate CD8 CTL responses
Introduction in vivo. Similar results were obtained more recently with
membrane anchored gp96 generated by replacement
CD8 CTL and NK cells are critical effectors for the of KDEL with a transmembrane domain (Zheng et al.,
elimination of intracellular parasites and for tumor rejec- 2001).
tion. Perforin is a pore-forming molecule related to com- Here we are using adoptively transferred TCR trans-
plement component C9 (Henkart and Henkart, 1982; Po- genic CD8 cells (Kearney et al., 1994) to quantitate and
dack and Dennert, 1983); it is expressed constitutively study the molecular and cellular mechanisms of CTL
in NK cells and inducibly in CTL and has been shown expansion by tumor-secreted gp96-Ig in vivo. The stud-
to be an important molecule for the elimination of virus- ies led to the discovery of an unexpected function for
infected and tumor cells (Kagi et al., 1994; Lichtenheld perforin and an unexpected mechanism by which NK
et al., 1988; Smyth et al., 1990, 1999). Perforin has also cells enable the clonal expansion of CD8 CTL.
been shown to participate in the clonal contraction of
CD8 CTL, although the mechanism of this effect has
Results
remained controversial (Kagi et al., 1999; Matloubian
et al., 1999; Spielman et al., 1998; Stepp et al., 2000).
Expansion of Cognate CD8 Cells and NK Cells
Interferon- (IFN) is well recognized for its anti-infectious
in Response to Tumor-Secreted gp96-Ig
and antitumor function by activating antigen-presenting
OT-1 cells are CD8 TCR transgenic T cells expressingcells (Schreiber, 1984, 1988). A role for IFN- in clonal
a clonal T cell receptor recognized by antibodies tocontraction of CD8 CTL has recently been described
v2 and v5.1-2 and by Kb-tetramers associated with the(Badovinac and Harty, 2000).
ovalbumin-derived peptide SIINFEKL (Hogquist et al.,Perforin is one of the primary cytolytic molecules ex-
1994). CD8 cells in the spleen cells of OT-1 transgenicpressed by activated lymphocytes and deployed during
mice are largely TCR transgenic and stain with anti v2the effector phase of the immune response. A role for
(Figures 1A and 1B). Upon purification of OT-1 by mag-NK cytotoxicity in inducing a CTL response to CD70-
netic selection with anti-CD8, 93% of the purified gatedexpressing tumors was recently reported (Kelly et al.,
lymphocyte population are CD8 positive. About 90% of2002) suggesting that NK cell-mediated lysis can trigger
these CD8 cells stain with tetramer (Figures 1C and 1D)T cell-mediated immunity. As demonstrated in this re-
or the specific v-region antibodies (data not shown).port, perforin expression in addition to IFN-was essen-
To facilitate detection of OT-1, we have also bred thetial for NK cell activation and for the clonal expansion
transgene into gfp transgenic mice (Ikawa et al., 1998)
to generate gfp-OT-1 that can be detected by FACS*Correspondence: epodack@miami.edu
even without antibody staining.1Present address: Department of Physiology and Immunology, Uni-
versity of Rijeka, Rijeka HR-51000, Croatia. In order to measure expansion of OT-1 in vivo, approx-
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imately one million of the purified cells were intrave-
nously transferred to syngeneic B6 mice (Kearney et al.,
1994). After 2 days resting, the mice were injected with
one million live EG7-gp96Ig cells intraperitoneally. EG7-
gp96Ig is a tumor derived from the EL4 lymphoma by
transfection with ovalbumin and with gp96-Ig. One mil-
lion EG7-gp96Ig secrete 50 ng gp96-Ig within 24 hr as
measured by ELISA (Yamazaki et al., 1999) (data not
shown). The secreted gp96-Ig chaperones ovalbumin
peptides via the CD91 receptor or other receptors (Ber-
win et al., 2002) into antigen-presenting cells, where the
ovalbumin peptides are further processed, presented
as Kb-SIINFEKL, and then trigger the specific clonal expan-
sion of cognate CD8 CTL including adoptively trans-
ferred OT-1. By increasing the frequency of ovalbumin-
specific CD8 cells to about 0.2%–0.5% by adoptive
transfer of OT-1, we hoped to create a sensitive in vivo
assay for CD8 CTL expansion in response to secreted
heat shock protein gp96-Ig.
The expansion of OT-1 after i.p. immunization with
live EG7-gp96Ig was determined in peripheral blood by
flow cytometry on days 0, 7, 14, and 21 by electronically
gating on CD8-positive lymphocytes and determining
the number of the Kb-SIINFEKL-tetramer positive cells (Figure
1E) or v2 positive cells (data not shown). In some experi-
ments spleen cells were analyzed and showed essen-
tially the same results as PBL. Within 1 week of EG7-
gp96Ig immunization, TCR transgenic OT-1 expanded
from a starting frequency of 0.5% to a mean frequency
of 4.5% with a range of 2% to 6.5% within the CD8
pool (Figure 1E). During the second week after primary
immunization OT-1 CTL contracted to a mean frequency
of 2%. A booster immunization with EG7-gp96Ig on day
14 reexpanded the OT-1 frequency to more than 3% of
the CD8 cells by day 21. The expansion of OT-1 was
dependent on secreted gp96-Ig. Vector (mock) trans-
fected EG-7 or untransfected EG-7 caused little OT-1
expansion (Figure 1F) in agreement with studies by oth-
ers (Dalyot-Herman et al., 2000). In addition, mice in-
jected with EG7 developed tumors and died while mice
Figure 1. Detection and Clonal Expansion of CD8 TCR Transgenic injected with live EG7-gp96Ig rejected the tumors (Ya-
T Cells (OT-1) in Response to Secreted gp96-Ig mazaki et al., 1999). Particularly noteworthy is the finding
(A–D) Characterization of OT-1 isolated from OT-1 transgenic mice. that the limited OT-1 expansion mediated by EG7 (with-
(A and B) Unpurified spleen cells from OT-1 mice were stained with out gp96-Ig secretion) is not followed by clonal contrac-anti-v2-PE specific for the  chain of the OT-1-TCR and with anti-
tion and secondary expansion upon boosting.CD8-Cy. (C and D) Purified CD8 cells from OT-1 transgenic mice. The
To exclude the possibility that the expansion of CD8purified cells were stained with anti-CD8-PE and Kb-SIINFEKL-tetramer-
APC (tetramer) (NIAID Tetramer Facility supported by the NIH AIDS CTL was an artifact of the cell transfer or of the peculiar
Research and Reference Reagent Program). The lymphocyte gate properties of OT-1 transgenic cells, we determined the
was analyzed by flow cytometry on a FACS Vantage (Becton Dickin- expansion of endogenous Kb-SIINFEKL-tetramer positive
son). The numbers represent the percentage of gated cells in the cells in the absence of OT-1 transfer. Endogenous tetra-
respective quadrant.
mer positive cells also expanded strongly after two im-(E–H) Clonal expansion of OT-1 cells, NK cells, and CD11c cells
munizations (data not shown). However, due to thein response to EG7-gp9Ig and EG7 (control). C57Bl/6 mice received
larger expansion of the adoptively transferred OT-1, im-one million purified OT-1 i.v. Two and fourteen days later (arrows
in [E] and [F]), they were injected i.p. with one million live EG7- proving signal to noise ratio, that system was preferred
gp96Ig (E, G, and H) or with one million live EG7 (F). Mice were bled in subsequent studies. Expanded OT-1 exhibited ef-
on days 0, 7, 14, and 21 and the PBL were analyzed for tetramer fector function as measured by ELI-spot assay for IFN-.
positive cells by staining with anti-CD8-PE and tetramer-APC or
The frequency of IFN--producing CD8 cells expandedwith anti-NK1.1-FITC or anti-CD11c-FITC. (E) Individual data from
in parallel with tetramer positive cells (data not shown).11 mice immunized with EG7-gp96Ig (arrows) analyzed in three sep-
arate experiments for CD8/tetramer double-positive cells or gfp-
OT-1-positive cells on the days indicated. Frequencies of OT-1 are
expressed as a percentage of total CD8 cells. (F) Same as in (E) expressed as a percentage of NK1.1-positive cells in the gate for
except that mice were immunized with EG7 that were not secreting large granular cells. (H) The frequency of CD11c-positive cells in
gp96-Ig (arrows). (G) NK1.1 cell frequency in peripheral blood of two blood after immunization with EG7-gp96Ig (arrows), expressed as
mice after primary immunization with EG7-gp96Ig. Frequencies are a percentage of PBL.
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Figure 2. LPS Cannot Substitute for gp96-Ig
Secretion; the Ig Portion of gp96-Ig Is Not
Required; gp96-Ig Release Allows Cross-
priming of OT-1
(A) Effect of SIINFEKL peptide and LPS on
OT-1, NK, and CD11c expansion. Groups of
three C57Bl/6 mice received one million OT-1.
Two days later they were injected i.p. with 50
g SIINFEKL with or without 50 g LPS as
indicated. Seven days later cell frequencies
were analyzed.
(B–D) Effect of EG7 and LPS. Groups of three
C57Bl/6 mice received one million OT-1 on
day 2. On days 0 and 14 they were injected
i.p. with one million EG7 plus 50 g LPS.
OT-1, NK1.1, and CD11c frequencies were
determined in PBL on the days indicated.
(E) The Ig-tail of gp96-Ig is not required;
C57Bl/6 mice received one million purified
OT-1 i.v. and 2 days later (day 0) either one
million EG7-gp96Ig or EG7-gp96myc-his6.
Four days later OT-1 expansion was mea-
sured by flow cytometry. Each group con-
tained three mice. Mean and SE of tetramer
positive cells in the CD8 gate are shown.
(F and G) One million purified gfp-OT-1 cells
were used as detection system. (F) Lewis lung
carcinoma cells were transfected with oval-
bumin and gp96-Ig and used for immuniza-
tion. One million cells producing 60 ng gp96-
Ig in 24 hr were injected i.p.
(G and H) Crosspriming of gfp-OT-1 expan-
sion by gp96-Ig-secretion. C57Bl/6 mice re-
ceived gfp-OT-1 as above and 2 days later
were injected i.p. with one million NIH-3T3-
gp96Ig-ova (G) or with one million NIH-3T3-
ova (H).
CTL expansion in response to viral infection is fre- of APC and that SIINFEKL, the antigenic peptide, was
provided directly by Kb on EG7. In order to evaluatequently preceded by NK cell activation and expansion
(Biron et al., 1986, 1999). Since cell damage by infection this possibility, we tested immune stimulation by the
combination of synthetic SIINFEKL peptide with LPSor trauma is expected to release heat shock proteins
including gp96 (Basu et al., 2000; Kotera et al., 2001), and the combination of EG7 with LPS. C57Bl/6 mice
that had received adoptively transferred OT-1 were im-we were interested to determine whether secreted gp96-
Ig was able to stimulate NK cell activation and expan- munized with SIINFEKL peptide in the presence or ab-
sence of LPS, and 1 week later OT-1, NK1.1, and CD11csion. NK cell frequencies in peripheral blood were deter-
mined with the NK1.1 (Figure 1G) and DX5 antibody frequencies were evaluated in blood (Figure 2A). SIIN
FEKL alone had a limited capacity to expand OT-1 to a(data not shown). Gating on large granular cells using
forward and side scatter revealed that the frequency of frequency of about 2% of all CD8 cells. Addition of LPS
to SIINFEKL did not significantly alter this effect. SIINNK1.1 cells was about 9% among the large granular
cells in peripheral blood (PBL) of untreated mice. Follow- FEKL had no effect on NK frequency while LPS with or
without peptide caused moderate NK expansion (froming EG7-gp96Ig injection, NK1.1cells expanded to 12%
(in the granular gate) within 24 hr in response to secreted 9% to 12% in the gate for granular cells). CD11c mobili-
zation was more strongly triggered by LPS, and thisgp96-Ig and then contracted to the starting level. Just
as untransfected EG-7 failed to support OT-1 expansion, effect was independent of peptide. We also evaluated
the combination of EG7 with LPS on OT-1, NK1.1, andEG7 also did not mediate NK1.1 expansion (data not
shown). CD11c expansion (Figures 2B–2D). EG7 even in combi-
nation with LPS was unable to expand and mobilize anySince gp96 has been reported to activate antigen-
presenting cells, we also determined the mobilization of of the populations to an extent similar to EG7-gp96Ig.
The data clearly indicate that SIINFEKL plus LPS or EG7CD11c-positive cells in blood and in the spleen. CD11c
cells increased 2-fold within 1 week after EG7-gp96Ig plus LPS cannot synergize and substitute for gp96-Ig-
ovalbumin-peptide complexes in NK and CTL expan-injection (Figure 1H) and returned to normal levels by 2
weeks. Boosting again doubled the frequency of sion, even though LPS and SIINFEKL individually have
effects on OT-1, NK, and CD11c cells.CD11c cells in PBL. These data suggest that secreted
gp96-Ig is able to expand CTL and NK cells and mobilize Although the Fc portion of IgG1 used in gp96-Ig has
low affinity for Fc receptors, we wanted to ascertain thatCD11c positive antigen-presenting cells (APC).
It was possible that gp96-Ig functioned as activator the gp96 domain and not the Ig domain of gp96-Ig was
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responsible for CTL and NK expansion. We therefore Perforin Deficiency Abrogates OT-1 Expansion
by Tumor-Secreted gp96-Igconstructed a gp96-myc fusion protein by substituting
The data indicate that CTL expansion caused by tumor-the Ig domain with the myc epitope followed by six
secreted gp96-Ig is preceded by NK activation. Whilehistidine residues (his6). Secretion of gp96-myc upon
this information indicates that heat shock proteins havetransfection into EG7 was verified by Western blots and
an effect on innate immunity through NK activationwas comparable to gp96-Ig using anti gp96 antibodies.
(Multhoff et al., 2000), the data do not answer the ques-EG7-gp96Ig and EG7-gp96-myc were compared in their
tion as to whether NK activation by gp96-Ig is relatedability to expand OT-1 in vivo (Figure 2E). Within 4 days
to CD8 CTL expansion. To address this question, NKafter immunization OT-1 had expanded similarly from
cells were depleted in wild-type C57Bl/6 mice with anti-0.5% to about 7% frequency, regardless of which form
asialo-GM2 or with anti-NK1.1. Depletion was checkedof gp96 was secreted by EG7. Therefore, the Ig part in
by flow cytometric analysis of PBL. The levels of NKgp96-Ig is not required for clonal expansion.
marker positive cells were 0.3% after depletion indicat-To exclude the possibility that the EG7 tumor has
ing a better than 90% in vivo removal (Figure 3D). NK-unique properties in this system of gp96-Ig secretion,
depleted mice received one million purified OT-1 cellswe transfected the Lewis lung carcinoma (LLC, C57Bl/
and 2 days later were immunized with EG7-gp96Ig.6) with ovalbumin alone or with ovalbumin and gp96-
Depletion of 90% of the NK cells resulted in a 50%Ig (LLC-gp96Ig-ova). In this experiment gfp-OT-1 were
reduction of OT-1 expansion when compared to fullyused, and they expanded to about 7% within 9 days in
NK-competent mice (Figure 3E). These data suggestedresponse to LLC-gp96Ig-ova immunization (Figure 2F);
that NK activation enhanced CTL expansion by secretedLLC-ova had no effect (data not shown). OT-1 expansion
heat shock protein gp96.could have been effected by direct stimulation through
The participation of NK cells in gp96-Ig-mediated CTLKb-SIINFEKL expressed by EG7-gp96Ig or LLC-gp96Ig-ova;
expansion raised the question as to which molecularsecreted gp96-Ig could have acted as a costimulus for
components of NK cells were required in this modelTCR stimulation of OT-1. Direct OT-1 TCR stimulation
system. NK cells mediate cytotoxicity by constitutivelyis not possible by allogeneic cells that do not express Kb;
expressing perforin and Fas-ligand and produce IFN-therefore, OT-1 expansion, if observed, has to proceed
upon stimulation. To determine whether any of thesethrough crosspresentation of ova-peptides by APC. We
NK mediators are required for CTL expansion by tumor-used NIH-3T3 cells as fully allogeneic cells. One million
secreted gp96-Ig, perforin knockout (PKO), IFN-NIH-3T3 cells transfected with ovalbumin and gp96-Ig
knockout (GKO), and Fas-ligand-defective (gld) micesecreted 250 ng gp96-Ig within 24 hr. OT-1 expansion
were analyzed for their ability to support OT-1 expansionwas similar (Figure 2G) when mice were injected with
in response to EG7-gp96Ig. The absence of perforinsyngeneic LLC-gp96Ig-ova or with allogeneic NIH-3T3-
in PKO mice completely abolished OT-1 expansion ingp96Ig-ova. NIH-3T3-ova not secreting gp96-Ig had no
response to EG7-gp96Ig (Figures 4A and 4B) after botheffect on OT-1 expansion (Figure 2H) despite its alloge-
primary and secondary immunization. The absence ofnicity, excluding OT-1 expansion by unspecific by-
Ifn- (GKO) strongly diminished OT-1 expansion (Figurestander activation. The data implicate dendritic cells
4B). In contrast to perforin and Ifn-, Fas-ligand is dis-or other antigen-presenting cells in CTL expansion by
pensable for OT-1 expansion following EG7-gp96Ig im-secreted gp96 fusion proteins.
munization. OT-1 expanded in Fas-L-defective mice al-
most as well as in wild-type mice after primary
immunization. Clonal contraction and secondary expan-NK Activation by gp96-Ig Precedes OT-1 Activation
sion, however, were diminished in gld mice. Perforin/The activation of NK cells and of CD8 CTL by secreted
Fas-ligand double-deficient mice (cdd), as expected,gp96-Ig raised the question of the interdependence of
did not support OT-1 expansion after EG7-gp96Ig immu-
the two phenomena and of the kinetics of the events.
nization.
OT1 expansion does not begin significantly until day
The activation of endogenous NK1.1 cells after EG7-
3 (72 hr) after injection of EG7-gp96Ig but then rises gp96Ig immunization was also impaired in PKO mice
continuously until day 7 (Figure 3A). In contrast, NK1.1 (Figure 5A), even though the adoptively transferred OT-1
activation and expansion is detectable and maximal al- used in the experiment are perforin sufficient. Similarly,
ready after 24 hr followed by contraction (Figure 3B). endogenous NK1.1 cells failed to be activated in GKO
On day 7 after immunization 5% of the NK1.1 cells are mice after EG7-gp96Ig injection (Figure 5B) indicating
tetramer positive, suggesting that they are derived from that perforin and Ifn- produced by adoptively trans-
OT-1 cells that express NK1.1. It has been reported that ferred normal OT-1 is not sufficient for NK and CTL
CD8-positive T cells upon activation can express NK expansion to gp96 in PKO or GKO mice. The findings
markers including NK1.1 (Lan et al., 2001; Stremmel et therefore indicate that perforin and Ifn- are necessary
al., 2001). We find that after 7 days up to 5% of the for both NK activation and CTL expansion in response
NK1.1-positive cells are tetramer positive, correspond- to gp96-Ig-peptide complexes, but that these two medi-
ing to about 10% of the expanded OT-1 cells. Taken ators are not derived from cognate CD8 CTL. Likely
together the data indicate that secreted heat shock pro- cellular candidates for releasing perforin and Ifn- are
tein gp96-Ig-peptide complexes mediate rapid NK cell NK cells constitutively expressing perforin and secreting
activation during the first 2 days, followed by CD8 CTL Ifn- upon stimulation.
(OT-1) expansion during the next 5 days. About 10% of Since wild-type OT-1 after differentiation to CTL ex-
the expanded OT-1 cells express NK markers and may press perforin, it was possible that an immune response
to adoptively transferred, perforin-expressing OT-1 inhave NK-like specificity (Stremmel et al., 2001).
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Figure 3. NK Activation Precedes OT-1 Ex-
pansion, and NK Depletion Abrogates OT-1
Expansion
(A–C) C57Bl/6 mice received one million puri-
fied OT-1 i.v. and 2 days later (day 0) one
million EG7-gp96Ig i.p. Blood samples were
obtained daily for 7 days and analyzed for
expression of tetramer cells in the CD8 gate
(A), for NK1.1 expression in a gate containing
large lymphocytes (B), and for tetramer/
NK1.1 double-positive cells (C). Data are from
four mice per group, showing the mean and
standard error.
(D and E) Effect of NK depletion on OT-1
expansion. For NK depletion anti-NK1.1 or
anti-asialo-GM2 (100 g) was injected twice
2 days apart to deplete NK cells. Control mice
received control IgG. (D) The frequency of
NK1.1 cells was analyzed 2 days after the last
injection by flow cytometry of PBL stained
with anti-NK1.1. (E) NK-depleted and control
mice (three in each group) received one mil-
lion purified OT-1 i.v. and 2 days later (day 0)
one million EG7-gp96Ig i.p. Tetramer positive
cells in the CD8 gate were analyzed in PBL
on days 0 and 7. The mean and SEM are
shown.
PKO mice abolished OT-1 expansion. We therefore bred into PKO mice restored the ability of EG7-gp96Ig immu-
nization to expand OT-1 even better than 5 million spleenthe OT-1 TCR transgene into the PKO background, gen-
erating perforin-deficient OT-1. Adoptive transfer of per- cells containing 200,000 NK cells (Figure 6B). The puri-
fied NK1.1 cells contained 2% CD8, 4% CD4 T cells,forin-deficient OT-1 into PKO mice did not restore their
ability to expand in response to EG7-gp96Ig immuniza- and 20% CD19/B220 B cells. The reconstitution data
of five mice in Figure 6 are consistent with the interpreta-tion (Figure 5C, third column). Therefore, the deficiency
of perforin, rather than an immune response to perforin, tion that perforin produced by wt NK cells is essential
and sufficient to restore OT-1 expansion in the PKOis responsible for the lack of OT-1 expansion in PKO
mice. As expected, OT-1 expansion (Figure 5D) and background in response to gp96-Ig. The data also indi-
cate that there is no defect other than perforin deficiencyNK1.1 activation (data not shown) are also not supported
in PKO by EG7. in PKO mice responsible for the failure of the CTL response
following gp96-Ig peptide complex immunization.
Perforin-Competent NK Cells Restore OT-1
Expansion in PKO Mice in Response Discussion
to gp96-Ig
Since normal OT-1 (not deficient in perforin or IFN-) do Heat shock proteins isolated from or secreted by tumor
cells are powerful tumor vaccines causing tumor rejec-not sustain their own expansion in the PKO or GKO
background in response to EG7-gp96Ig immunization, tion and generating specific memory (Palliser, 2001;
Singh-Jasuja et al., 2001; Srivastava and Amato, 2001;it seemed clear that perforin and IFN- needed to be
provided by non-CD8 cells. This hypothesis was tested Yamazaki et al., 1999). Using tumor-secreted gp96 or
tumor membrane-associated gp96, tumor rejection wasby adoptively transferring wt syngeneic spleen cells into
PKO mice and assessing OT-1 expansion in response found to be independent of CD4 cells but required the
participation of NK and CD8 cells. The current study wasto EG7-gp96Ig. Partial reconstitution of PKO mice with
five million wt spleen cells containing approximately designed to quantitate the CD8 and NK cell response in
vivo and to define the molecular and cellular mecha-200,000 NK1.1 cells largely restored OT-1 expansion
upon EG7-gp96Ig injection (Figure 6A). To further define nisms for the induction of the CTL response by gp96.
Tumor-secreted gp96 triggers tetramer-specific CD8the perforin-containing cell type responsible for restora-
tion of OT-1 expansion in the PKO background, we puri- CTL expansion in our model system to a high frequency
in vivo. Expansion of tetramer positive cells correlatedfied wt, syngeneic C57Bl/6 NK cells. Transfer of 500,000
perforin-sufficient NK1.1 cells of 75% to 80% purity with the frequency of IFN- ELI-spot forming cells (data
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Figure 4. Perforin and Ifn- Are Required but
Fas-Ligand Is Not Needed for OT-1 Expan-
sion by gp96-Ig
(A) OT-1 do not expand in PKO mice. One
million gfp-OT-1 were transferred i.v. to wt or
PKO mice, and the mice were immunized i.p.
on days 0 and 14 with 1 million EG7-gp96Ig.
Representative FACS profiles gated on CD8
cells are shown. The numbers indicate the
percentage of OT-1 cells in the CD8 gate.
(B) Wild-type and genetically deficient C57Bl/6
mice (as indicated in the graph) received one
million OT-1 i.v. Two days later (day 0) and
two weeks later (day 14) the mice received
one million EG7-gp96Ig i.p (arrows). Mice were
analyzed for tetramer/CD8 double-positive
cells on the days indicated. B6 are wt C57Bl/6
mice obtained from Jackson Laboratories.
Gld are homozygous Fas-ligand-defective
mice, bred in our facilities under pathogen-
free conditions. PKO are perforin-deficient
mice also bred in our facilities. GKO are Ifn--
deficient mice obtained from Jackson Labo-
ratories. Cdd mice are perforin/Fas-ligand
double (cytotoxic double) -deficient mice
(Spielman et al., 1998) and are maintained in
our facilities. Each group was composed of
four to six mice; OT-1 frequency is given as
a percentage of CD8 cells SEM.
not shown). Specific CD8 CTL frequencies of 50% within vided by NK cells is critical for NK and CTL expansion.
The question of whether normal NK cells or CD1-specificthe CD8 pool have been observed after viral challenge
of adoptively transferred, TCR transgenic CD8 cells (Re- NK-T cells are involved in triggering CTL and NK expan-
sion by gp96 is currently under study.ich et al., 2000). The activation of endogenous NK cells
is an additional indicator of the strength of the immune The inability of Fas-ligand to substitute for perforin
may be explained in two ways. Fas-ligand may be unablestimulus by gp96. As shown previously, the immune
response clearly is associated with effector function, to lyse the target cell, or Fas-ligand-mediated apoptosis,
as opposed to perforin-mediated killing, does not sup-gp96Ig-secreting tumors are rejected, and specific
memory is generated (Yamazaki et al., 1999), while non- port subsequent NK and CTL expansion. The latter ex-
planation would suggest that lysis by perforin and gran-gp96-secreting tumors are lethal. In ongoing studies we
are assessing the effect of the presence of a wild-type, ules may be qualitatively different from apoptotic death
by Fas-ligand. It is still controversial, however, whethernonsecreting tumor on CD8 CTL expansion in this sys-
tem. Initial data suggest that frequent vaccinations are apoptotic death is less immunogenic than death by ne-
crosis and trauma (Kotera et al., 2001; Somersan etrequired to sustain the CTL response.
A surprise in this study was the unexpected finding al., 2001). PKO mice immunized with unirradiated EG7-
gp96Ig, in contrast to wild-type mice, develop tumorsthat perforin-deficient mice were unable to support CD8
CTL expansion by gp96, pointing to a role for cytotoxic- with high incidence (data not shown). Therefore, the
inability of PKO mice to mediate NK and CTL expansionity in the afferent arm of the immune response. That the
cytotoxic activity of perforin is mediated by NK cells is correlates with increased susceptibility even to gp96-
secreting tumors. Gp96-Ig vaccination, even in the ab-suggested in depletion and reconstitution experiments.
Perforin could not be substituted by Fas-ligand. Perforin sence of adoptive OT-1 transfer, allows the rejection of
EG7 tumors preestablished for 3 or 5 days, supportingand Ifn- expressed by activated wild-type OT-1 was
not able to reconstitute CTL and NK expansion in PKO the effectiveness of the NK and CTL response (Yamazaki
et al., 2002).mice. Perforin and Ifn- expression in CD8 cells requires
2 to 3 days activation, while perforin and Ifn- are avail- Gp96 is taken up by dendritic cells and leads to their
activation (Basu et al., 2001). The ability of allogeneic,able instantly in NK cells. NK activation after EG7-gp96Ig
immunization is very rapid and essential for subsequent ovalbumin-transfected, and gp96-Ig secreting 3T3 cells
to expand OT-1 by crosspriming clearly implicates anti-CD8 expansion. NK cell adoptive transfer and depletion
experiments support the conclusion that perforin pro- gen-presenting cells, most likely dendritic cells. We sug-
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Figure 6. Reconstitution of OT-1 Expansion in Perforin-Deficient
(PKO) Mice by Perforin-Competent Splenocytes or NK Cells
(A) Groups of PKO mice received five million syngeneic, wild-type
splenocytes (containing 200,000 NK1.1 cells) together with one mil-
lion OT-1 as indicated. Two days later (day 0) the mice received one
million EG7-gp96Ig i.p. and were analyzed for OT-1 expansion by
tetramer assay on days 0 and 7.
(B) Wild-type NK cells were purified to 76% purity from nonadherent
spleen cells by NK1.1-positive selection on MACS columns. Five
hundred thousand cells of the purified population containing
375,000 purified NK1.1 cells were adoptively transferred together
with one million OT-1, and 2 days later the mice received one million
EG7-gp96Ig i.p. Analysis was performed as in (A).
Figure 5. Perforin and Ifn- Deficiency Limit NK Expansion in Re-
sponse to gp96-Ig
IFN- is needed first for NK and subsequently for CTL(A and B) PKO and GKO mice and wt controls received OT-1 on
expansion by gp96-Ig. A small proportion (up to 10%)day 2 and were immunized with one million EG7-gp96Ig on days 0
and 14. NK1.1 frequency in PBL was analyzed on the days indicated. of the CTL expanded by gp96-Ig expresses NK markers
(C) Perforin-deficient OT-1 do not expand in PKO mice to gp96-Ig. and may have antigen specificities more similar to NK
Perforin-deficient OT-1 cells were generated by breeding the OT-1 in addition to MHC-restricted cytotoxicity. Expression
TCR transgene into PKO mice. Perforin-deficient mice and wt con-
of NK markers on CTL may regulate their interactiontrols received one million purified normal OT-1 or purified, perforin-
with DC including protection from lysis.deficient OT-1 i.v. (as indicated) and 2 days later (day 0) one million
Lymphocytic choriomeningitis virus infection resultsEG7-gp96Ig. After 7 days OT-1 expansion was measured by flow
cytometry. Groups of four mice were analyzed, and the mean and in normal CTL expansion even in PKO mice (Badovinac
SEM are shown. and Harty, 2000; Kagi et al., 1994; Matloubian et al.,
(D) PKO mice do not support OT-1 expansion in response to EG7. 1999; Walsh et al., 1994). Viral infection and replication
PKO mice received 1 million OT-1 on day 2 and were injected i.p.
generates numerous inflammatory signals that maywith one million EG7 on days 0 and 14 (arrows). OT-1 in PBL were
eliminate the need for perforin in the afferent phase ofidentified by double staining with anti-v2 and anti-CD8.
the immune response. NK activity and perforin therefore
appear to be particularly important for the generation of
CTL to immunogens, such as gp96-peptide complexes,gest that gp96-Ig activates dendritic cells that in turn
activate NK cells, signaling IFN- secretion by NK and generated in a noninflammatory environment, such as dur-
ing tumor transformation or during immune suppression.triggering perforin-mediated lysis of susceptible targets.
Ongoing in vitro studies using purified NK, DC, OT-1, Our findings have implications in understanding the
interconnections between innate and adaptive immunity,and EG7-gp96Ig or EG7 support this conclusion. Three
reports (Ferlazzo et al., 2002; Gerosa et al., 2002; Piccioli immune regulation, immune suppression, and vaccine
therapy. Immune suppression by tumors and by HIVet al., 2002) published while this manuscript was written,
document human NK/DC interaction in vitro. NK and DC infection is frequently preceded by loss of NK activity.
Diminished NK activity, similar to perforin deficiency,can reciprocally activate each other, and NK cells are
able to kill immature DC more efficiently than mature eliminates the ability of NK cells to lyse target cells and
respond to gp96 and may be responsible for the lackDC, supporting earlier reports (Carbone et al., 1999;
Poggi et al., 2002; Wilson et al., 1999). Activated NK of NK activation and the subsequent failure of CD8
expansion to tumor or viral antigens. In support of thiscells are also able to lyse EL4 and its derivative EG7
(Kalland et al., 1987; Matsumoto et al., 2000). Our in hypothesis we have observed previously that perforin-
deficient T cells transplanted with allogeneic bone mar-vivo data are consistent with the model of reciprocal
activation of DC and NK and identify secreted gp96-Ig row grafts cause delayed onset of graft versus host
disease and delayed mortality. The inability of theseas one trigger for this positive feedback loop. Perforin
and IFN- produced by NK according to this model grafts to mediate perforin-dependent killing of alloge-
neic targets may limit the amplification of the initial re-are the molecular mediators sustaining the loop that is
interrupted by their deficiency and terminated by the sponse (Baker et al., 1996). By the same reasoning,
cellular vaccines may need to activate both NK andclearance of antigen. The positive feedback cycle be-
tween NK and dendritic cells requiring perforin and cognate CTL responses for effectiveness and maximal
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Purification of CD8 OT-1 Cellsstimulation of CD8 CTL responses and memory. Secre-
Spleen cells from OT-1 TCR transgenic mice were purified by posi-tion of heat shock proteins by engineered tumor cells
tive column selection using MACS anti-CD8a (Ly-2) MicroBeadsopens one way for the production of effective tumor cell
(Miltenyi Biotec, Auburn, CA). Splenocytes were resuspended in 90
vaccines that provide both adjuvanticity for NK activa- l of buffer (PBS containing 0.5% BSA) per 107 total cells and 10
tion and antigenicity for CTL generation. l of microbeads added. After 15 min incubation at 6C–12C, cells
were washed and used for magnetic separation on LS columns.
Purified cells were 	95% CD8 as judged by FACS analysis.Experimental Procedures
Cell Lines Purification of NK1.1 Cells
EG7 were obtained from Dr. M. Bevan (U. of Washington, Seattle) Spleen cells from C57BL/6 mice were allowed to adhere to plastic
and transfected with the bovine papilloma-derived vector pCMG- dishes for 1 hr. Nonadherent cells were collected and purified by
His containing gp96-Ig or gp96-myc as described (Yamazaki et al., positive column selection using mouse anti-DX5 MicroBeads (Mil-
1999). Controls were transfected with vector alone. Lewis lung carci- tenyi Biotec, Auburn, CA). Cells were resuspended in 80 l of buffer
noma (LLC) and NIH-3T3 cells, obtained from the American Tissue (PBS containing 0.5% BSA) per 107 total cells and 20 l of mi-
Culture Collection, were transfected with ovalbumin in pAC-Neo- crobeads added. After 15 min incubation at 6C–12C, cells were
ova (generously provided by Dr. M. Bevan (Hogquist et al., 1994) washed and used for magnetic separation on a MS column. The
and with pCMG-His-gp96-Ig or with vector alone as control. resulting cells were 73%–76% NK1.1 as judged by FACS analysis.
Adoptive Transfer of TCR Transgenic T CellsMice
Sex-matched purified CD8 cells (106 ) from naive OT-1 TCR trans-C57Bl/6 and B6 IFN- knockout mice were obtained from Jackson
genic mice or gfp-OT1 mice were injected intravenously in a volumeLaboratories. Gfp mice were obtained by permission of the produc-
of 0.2 ml PBS into normal nonirradiated B6 mice, PKO, GKO, or gld/ers (Ikawa et al., 1998); they were bred with OT-1 mice (obtained from
gld mice.Dr. M. Bevan) to generate gfp-OT-1-expressing green fluorescent
protein. B6 perforin knockout mice (Kagi et al., 1994) and gld mice
Immunizationswere maintained under pathogen-free conditions in our own facil-
C57Bl/6 mice received one million of purified OT-1 i.v. on day 2. Onities.
days 0 and 14 mice were injected with one million nonirradiated
EG7-gp96-Ig, EG7-gp96-myc-his6, LLC-gp96Ig-ova, NIH3T3-Antibodies
gp96Ig-ova, or with EG7, LLC-ova, or NIH-3T3-ova intraperitoneallyDirectly conjugated monoclonal antibodies, including PE- and Cy-
in a volume of 0.4 ml PBS. OT-1 expansion was measured in bloodChrome-conjugated anti-mouse CD8a, FITC-conjugated anti-
or spleens by flow cytometry 4, 7, 14, and 21 days later. As controls,mouse NK1.1, PE-conjugated anti-mouse V2, FITC-conjugated
mice were immunized with the synthetic ovalbumin derived peptideanti-mouse V5.1,5.2, FITC-conjugated anti-mouse CD11c, and PE-
SIINFEKL (50 g) or EG7 and LPS (E. coli, Diffco, Detroit, MI) (50conjugated anti-mouse DX5 were purchased from PharMingen (San
g) or a combination of the agents.Diego, CA). Isotype controls, rat IgG2a (PE), mouse IgG2a (FITC),
mouse IgG1 (FITC), and hamster IgG1 
 (FITC) were purchased from
NK DepletionPharMingen (San Diego, CA). Prior to staining, spleen cells and
C57BL/6 mice were depleted of NK cells using rabbit anti asialo-peripheral blood lymphocytes were treated with purified anti-mouse
GM1 antibody (anti-ASGM1) (WakoPure Chemicals Inc, Richmond,CD16/CD32 (Fc-III/II receptor, Pharmingen). Kb-tetramer associ-
VA) (Wang et al., 1998). Mice were injected twice intraperitoneallyated with OVA peptide (SIINFEKL) and APC conjugated was obtain
with 40 l of anti-ASGM1 diluted in 0.5 ml of PBS or only PBS asfrom the NIH-supported Tetramer Core Facility. Tetramer was ti-
control on days 4 and 2 before OT-1 transfer. Depletion of NK1.1trated and used at a final dilution of 1:50.
cells was confirmed by flow cytometry and shown to be greater
than 90%.Flow Cytometry—Analysis of TCR Transgenic T Cells
The magnitude of an antigen-specific immune response was deter-
NK Reconstitution into PKOmined by enumerating CD8 T cells by staining with antibodies to a
Sex-matched purified NK1.1 cells (5 105 ) and purified OT-1 CD8particular variable (V) region  (V2) or V (V5.1,5.2) chains or with
were transferred into nonirradiated PKO mice on day 2, and 2 daysKb-tetramer (loaded with SIINFEKL) using three-color flow cytome-
later the mice received one million EG7-gp96Ig i.p.try. In some experiments as indicated in the text, gfp-OT-1 were
detected in the FITC channel by FACS analysis without staining.
Acknowledgments2  105 peripheral blood lymphocytes were stained with APC-
labeled Kb-tetramer associated with SIINFEKL for 1 hr at 4C. Cells
We are grateful to Dr. M. Bevan for providing OT-1 mice, EG7 cells,were washed twice in FACS buffer (PBS containing 0.5% BSA, 0.1%
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blatt (U. of Miami), and M. Lotze (U. of Pittsburgh) for criticallywere then added for an additional 30 min. Events were acquired
reading the manuscripts and for their comments. This work wason a FACS Vantage flow cytometer (10,000–20,000 events were
supported by USPHS grants NIH, RO1 CA80228, and CA 39201. Kb-collected in a CD8 electronic gate), and the data were analyzed
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and GKO, peripheral blood lymphocytes were incubated with Kb-
tetramer (SIINFEKL) as described followed by incubation with sur-
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